Delivery Order SPE2DB22D2206-SPE2DB24FJD58
Award Date
7/11/24
Potential Completion Date
8/1/24
Potential Value
$9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,655.40 firm fixed-price delivery order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $9,565.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPZELCA 4 MG VIALS, a pharmaceutical product, with a completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $18,051.52, is for the delivery of the pharmaceutical product Zepzelca 4 mg vials. This is a firm fixed price delivery order contract with a period of performance through September 30, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $9,025.76 to supply ZEPZELCA 4 MG VIALS. The order has a completion date of February 2, 2024 and was awarded on January 11, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to support DLA Troop Support Medical programs. No set-aside designation was...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $8,890.86 firm fixed price contract is for the delivery of ZEPZELCA 4 MG VIALS, a pharmaceutical product, to support DLA Troop Support Medical facilities. The contract has a completion date of January 19, 2024. No set-aside designation was used. AmerisourceBergen Drug Corp, a for-profit organization, is a prime...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of ZEPZELCA 4 MG VIALS, a pharmaceutical product, with a potential value of $9,025.76 and a completion date of January 30, 2024. No set-aside designation was used. Amerisourcebergen Drug Corporation, through its Corporate Office division, is a prime contractor that provides...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg vials of the cancer drug ZEPZELCA, with a ceiling value of $9,025.76 and an ultimate completion date of September 12, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen has been awarded...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $1,393.14 firm fixed-price contract is for the supply of the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML." This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which enables DLA to efficiently...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4 mg vials of the drug Zepzelca. The fixed-price, firm-fixed-price delivery order has a ceiling value of $18,675.40 and an ultimate completion date of January 9, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,565.56, is for the delivery of ZEPZELCA 4 MG VIALS, a specialty medication. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...